Cipla Limited on Wednesday announced the launch of Yurpeak (tirzepatide), a once-weekly injectable therapy for the management of obesity and type 2 diabetes mellitus (T2DM) -- two of the country's most pressing health challenges.
Washington D.C. [USA], April 11 (ANI): To provide healthcare practitioners with an easy-to-perform and time-efficient screening tool for type 2 diabetes (T2DM), researchers have developed a valuable new grip strength metrics. The practitioners can use this assessment of normalised grip stren
Washington DC [USA], April 6 (ANI): In a recent study, researchers have developed a valuable new grip strength metrics that provide healthcare practitioners with an easy-to-perform and time-efficient screening tool for type 2 diabetes (T2DM). The study advocates that healthcare practitioners
Washington D.C. [USA], Aug 21 (ANI): To date, the underlying causes of inflammation in obesity and type 2 diabetes mellitus (T2DM) have been poorly understood, but a new research seems to have made a breakthrough by finding that that changes to mitochondria--the powerhouse of cells--drive ch